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EVALI During the COVID-19 Pandemic: A Needle in the Ground Glass
Derek J. Fikse, DO; Alexandra Amaducci, DO; Kenneth Katz, MD; Matthew Nimmo, DO

Lehigh Valley Health Network, Department of Emergency and Hospital Medicine/USF Morsani College of Medicine, Allentown, Pa.

Background

COVID-19 pneumonitis has become a
predominant respiratory diagnosis in the
Emergency Department (ED). Consequently,
other disease processes could be overlooked –
especially in younger patients – including
E-cigarette or Vaping Product Use-Associated
Lung Injury (EVALI). A case of a patient with
EVALI mistaken for COVID-19 is presented.
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Case Description

A 16-year-old boy with past medical history of
asthma presented to the ED with dyspnea and
cough of abrupt onset 24 hours prior to ED
visit. He had been using his home albuterol
without improvement. There were no known
sick contacts, but patient was employed at a
chain restaurant. Notable vital signs included:
heart rate 116 beats per minute, respiratory
rate 32, room air pulse oxygenation 90% (with
a change to 99% on high flow nasal canula
40L/50%), temperature 100.2˚F. Chest x-ray
demonstrated bilateral pulmonary infiltrates
concerning for multifocal pneumonia and
possible evolving acute respiratory distress
syndrome (ARDS). Chest computerized
tomography (CT) scan revealed: “Diffuse
bilateral ground glass opacities. Considerations
include viral and atypical pneumonia, including
COVID-19 pneumonitis.” Notable blood work
included: white blood cell count 19.4 thou/cm

(reference 3.8-10.4 thou/cm) and troponin I
0.27 ng/mL (<0.03 ng/ml). Both urine drug
screen of abuse and serum liquid chromatography
– mass spectrometry (LC-MS) detected
tetrahydrocannabinol (THC). Patient was
admitted to the pediatric intensive care unit with
presumptive diagnosis of COVID-19 infection.
On hospital day (HD) 1 patient was transitioned
to BiPAP for worsening tachypnea. Blood
culture, urine legionella, and respiratory viral
panel (including COVID-19) returned negative.
Respiratory viral panel was repeated and
again returned negative. Upon further inquiry,
patient reported vaping on the day his
symptoms began and smoking cannabis
regularly. Treatment remained supportive with
supplemental oxygen and intermittent albuterol/
ipratropium nebulization. Patient was weaned
from oxygen by HD 5 and discharged in stable
condition on HD 6.

Discussion

EVALI is defined as recent vaping use with
development of pulmonary infiltrates on chest
imaging in the absence of another identifiable
cause. Although EVALI is associated with vape
liquid containing THC and vitamin E acetate,
no single agent has been definitively
implicated. Typically, EVALI is associated with
counterfeit or user filled cartridges. However,
this patient reported a single use vape
pen purchased from a convenience
store. EVALI treatment is primarily
supportive with supplemental
oxygen, bronchodilators, steroids,
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and vaping cessation.

Conclusion

Despite COVID-19, it is imperative to obtain a
detailed social history and to maintain a broad
differential in patients with acute respiratory
complaints.

